Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients
NCT00691548
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Stage IV Cancer
Interventions
DRUG:
Cetuximab-Zr. 89
Sponsor
Maastricht Radiation Oncology
Collaborators
[object Object]